Trial Profile
A Prospective, Double-blind, Randomized, Active Controlled, Parallel Group, Multicenter Phase II Clinical Trial to Evaluate the Effectiveness of X-22 as a Smoking Cessation Aid
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Nov 2021
Price :
$35
*
At a glance
- Drugs Nicotine (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- Sponsors 22nd Century
- 16 Jun 2021 Status changed from active, no longer recruiting to completed.
- 22 Apr 2014 New trial record